Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Articles by : Bella Czajkowski, National Correspondent
Three drugmakers recently announced refunds for 340B covered entities that were overcharged when buying certain drugs. Viatris, Amgen and GSK [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Multiple hospital advocacy groups have filed an amicus brief urging a federal district judge to uphold Nebraska’s recently enacted 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Three drugmakers recently announced they will exempt additional states from their 340B contract pharmacy restrictions in light of new contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The 340B program is driving up employer-sponsored health insurance premiums, according to a drug industry-funded white paper. Provider advocates criticized [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Four drugmakers recently announced they will exempt additional states from their 340B contract pharmacy restrictions in response to a flurry [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Federal appeals court judges on Friday questioned whether four major insulin manufacturers could have imposed similar 340B contract pharmacy restrictions [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The U.S. Supreme Court on Tuesday sided against more than 200 hospitals in a dispute over Medicare disproportionate share hospital [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Recent Health Resources and Services Administration (HRSA) audits found that two drugmakers overcharged covered entities for their 340B drugs, fueling [...] …